Dreman Value Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Dreman Value Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$4K	Hold	36	–	–	﹤0.01%	447
2017 Q4	$4K	Hold	36	–	–	﹤0.01%	441
2017 Q3	$4K	Hold	36	–	–	﹤0.01%	421
2017 Q2	$4K	Buy	+36	New	+$4.07K	﹤0.01%	422
2017 Q1	–	Sell	-36	Closed	-$4K	–	392
2016 Q4	$4K	Sell	36 -378	-91%	-$39.6K	﹤0.01%	407
2016 Q3	$46K	Buy	414 +157	+61%	+$20.8K	0.03%	237
2016 Q2	$37K	Buy	257 +85	+49%	+$12.1K	0.02%	259
2016 Q1	$25K	Hold	172	–	–	﹤0.01%	375
2015 Q4	$27K	Sell	172 -188	-52%	-$27.4K	0.01%	175
2015 Q3	$51K	Hold	360	–	–	0.01%	373
2015 Q2	$52K	Buy	+360	New	+$51.3K	﹤0.01%	384

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dreman Value Management's TARO Position: Q1 2018 in Review

Dreman Value Management held its Taro Pharmaceutical Industries Ltd. (TARO) position steady in Q1 2018 at 36 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #447.

Dreman Value Management first reported a position in TARO in Q2 2015 and has held it in 11 quarters since. The position peaked at $52K in Q2 2015. 109 funds tracked by Wall St. Rank hold TARO as of Q1 2018.

Dreman Value Management held 36 shares of Taro Pharmaceutical Industries Ltd. worth $4K as of Q1 2018.
Dreman Value Management left its Taro Pharmaceutical Industries Ltd. share count unchanged in Q1 2018.
Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Dreman Value Management's portfolio in Q1 2018, its #447 holding.
Dreman Value Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2015 and has held it in 11 quarters since.
Dreman Value Management's Taro Pharmaceutical Industries Ltd. position peaked at $52K in Q2 2015.
109 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2018.

Based on Dreman Value Management's 13F filing for Q1 2018, filed 2 May 2018.